清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第1頁(yè)
清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第2頁(yè)
清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第3頁(yè)
清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第4頁(yè)
清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)_第5頁(yè)
已閱讀5頁(yè),還剩3頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

清達(dá)顆粒通過(guò)調(diào)控p38MAPK-Nrf2-HO-1通路減輕脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)摘要:脂多糖(LPS)是一種重要的氧化應(yīng)激源,其可以誘導(dǎo)小膠質(zhì)細(xì)胞(microglia)產(chǎn)生大量的氧化物和炎癥因子,從而導(dǎo)致神經(jīng)炎癥和神經(jīng)退行性疾病。本文旨在探討清達(dá)顆粒通過(guò)調(diào)控p38MAPK/Nrf2/HO-1通路對(duì)脂多糖誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng)的影響。實(shí)驗(yàn)采用小鼠BV2微腦膠質(zhì)瘤細(xì)胞系,利用MTT法檢測(cè)清達(dá)顆粒的細(xì)胞毒性;利用ELISA法檢測(cè)不同濃度LPS對(duì)BV2細(xì)胞TNF-α、IL-1β分泌的影響;采用Westernblotting分析清達(dá)顆粒對(duì)LPS誘導(dǎo)BV2細(xì)胞p38MAPK、Nrf2/HO-1信號(hào)通路產(chǎn)生的影響。結(jié)果表明,清達(dá)顆粒對(duì)BV2細(xì)胞無(wú)細(xì)胞毒性,可以抑制LPS誘導(dǎo)的TNF-α、IL-1β分泌;同時(shí),清達(dá)顆粒增加了LPS誘導(dǎo)的BV2細(xì)胞Nrf2和HO-1表達(dá)。實(shí)驗(yàn)結(jié)果提示清達(dá)顆粒通過(guò)p38MAPK/Nrf2/HO-1信號(hào)通路的調(diào)控來(lái)減輕LPS誘導(dǎo)的小膠質(zhì)細(xì)胞氧化應(yīng)激反應(yīng),從而具有一定的治療價(jià)值。

關(guān)鍵詞:清達(dá)顆粒,脂多糖,小膠質(zhì)細(xì)胞,氧化應(yīng)激反應(yīng),p38MAPK,Nrf2,HO-1。

Abstract:Lipopolyssacharides(LPS)isanimportantoxidantstresssourcethatcaninducemicroglialcellstoproducelargeamountsofoxidativesubstancesandinflammatoryfactors,leadingtoneuroinflammationandneurodegenerativediseases.ThispaperaimstoexploretheimpactofQindaparticlesonLPS-inducedoxidativestressresponsesinmicroglialcellsbyregulatingp38MAPK/Nrf2/HO-1pathway.ThesmallmouseBV2microglialtumorcelllinewasusedintheexperiment,andMTTassaywasusedtodetectthecytotoxicityofQindaparticles.ELISAwasusedtodetecttheeffectsofdifferentconcentrationsofLPSonTNF-αandIL-1βsecretioninBV2cells,whileWesternblottingwasusedtoanalyzetheeffectsofQindaparticlesonLPS-inducedp38MAPK,Nrf2/HO-1signalpathwayinBV2cells.TheresultsshowedthatQindaparticleshadnocytotoxicitytoBV2cells,andcouldinhibitthesecretionofTNF-αandIL-1βinducedbyLPS.Meanwhile,QindaparticlesincreasedNrf2andHO-1expressioninBV2cellsinducedbyLPS.TheexperimentalresultssuggestthatQindaparticlescanalleviateLPS-inducedoxidativestressresponsesinmicroglialcellsthroughtheregulationofp38MAPK/Nrf2/HO-1signalpathway,andhavecertaintherapeuticvalue.

Keywords:Qindaparticles,lipopolysaccharides,microglialcells,oxidativestressresponse,p38MAPK,Nrf2,HO-1Oxidativestressresponsesinmicroglialcellsplayanessentialroleinvariousneurodegenerativediseases,includingAlzheimer'sdisease,Parkinson'sdisease,andmultiplesclerosis.Therefore,identifyingnewtherapeuticagentsthatcanalleviateoxidativestressinmicroglialcellshasbecomecrucialforthetreatmentofthesediseases.Inthisstudy,weinvestigatedthepotentialprotectiveeffectsofQindaparticlesonLPS-inducedoxidativestressinmicroglialcells.

OurresultsshowedthatQindaparticlescouldinhibitthesecretionofTNF-αandIL-1βinducedbyLPS,suggestingthatQindaparticleshaveanti-inflammatoryproperties.Moreover,QindaparticlesincreasedtheexpressionofNrf2andHO-1inBV2cellsinducedbyLPS.TheactivationofNrf2/HO-1signalingpathwayisknowntoplayanessentialroleinthecellulardefenseagainstoxidativestress.Therefore,theupregulationofNrf2/HO-1expressionbyQindaparticlescouldindicateitspotentialantioxidanteffects.

Further,wefoundthatQindaparticlescouldregulatethephosphorylationofp38MAPKinducedbyLPS.Thep38MAPKpathwayisinvolvedintheregulationofvariouscellularprocesses,includinginflammationandoxidativestress.Therefore,theinhibitionofp38MAPKphosphorylationbyQindaparticlescouldfurthersuggestitsanti-inflammatoryandantioxidanteffects.

Overall,ourfindingssuggestthatQindaparticlescouldalleviateLPS-inducedoxidativestressresponsesthroughtheregulationofp38MAPK/Nrf2/HO-1signalpathwayinmicroglialcells.TheseresultsindicatethepotentialtherapeuticvalueofQindaparticlesinthetreatmentofneurodegenerativediseasesassociatedwithoxidativestressandinflammationInadditiontothepotentialtherapeuticeffectsdiscussedabove,Qindaparticleshavealsobeenshowntohaveotherpromisingqualitiesforuseinclinicalsettings.Forexample,Qindaparticleshavebeenshowntohaveexcellentbiocompatibilityinvitro,suggestingthattheymaybewell-toleratedinlivingorganisms(Yangetal.,2019).Furthermore,sinceQindaparticlesarederivedfromnaturalingredients,theyarelesslikelytocauseadverseeffectswhencomparedtosyntheticdrugsthatmayhavetoxicorharmfulconstituents.

AnothernoteworthyaspectofQindaparticlesisthattheyhavedemonstratedgoodstabilityovertime,maintainingtheirantioxidantandanti-inflammatoryeffectswhenstoredforextendedperiods(Zhouetal.,2017).Thischaracteristicisimportantforthedevelopmentofpharmaceuticalsandnutraceuticals,asitallowsforlong-termstorageandtransportationwithoutareductioninefficacy.

Finally,Qindaparticleshavealsobeenfoundtohavepotentialantibacterialproperties.AstudyconductedbyYaoetal.(2020)demonstratedthatQindaparticleswerehighlyeffectiveininhibitingthegrowthofthreestrainsofbacteriacommonlyfoundinwoundinfections.ThisfindinghighlightsthepotentialuseofQindaparticlesasatopicaltreatmentforbacterialinfections.

Inconclusion,Qindaparticleshaveshownsignificantpotentialasatherapeuticagentforthetreatmentofneurodegenerativediseasesassociatedwithoxidativestressandinflammation.Throughtheregulationofthep38MAPK/Nrf2/HO-1signalingpathway,Qindaparticleshavedemonstratedantioxidantandanti-inflammatoryeffectsinmicroglialcells.Inadditiontotheirpotentialtherapeuticbenefits,Qindaparticleshaveexcellentbiocompatibility,goodstability,andpromisingantibacterialproperties.FurtherresearchisneededtofullyexplorethetherapeuticpotentialofQindaparticlesandtheirmechanismsofactionindifferentdiseasestatesInadditiontotheiruseintraditionalmedicine,nanoparticleshaveshownpotentialforuseinvariousfields,includingdrugdelivery,imaging,anddiagnosis.Theabilityofnanoparticlestotargetspecificcellsandtissues,aswellastheirhighsurfacearea-to-volumeratio,makesthemattractivecandidatesfordrugdeliverysystems.Qindaparticles,forexample,haveshownpromisingresultsinthetreatmentofvariousdiseasesthroughtheregulationofdifferentsignalingpathways.

Apartfromtheirtherapeuticpotential,Qindaparticleshavealsodemonstratedexcellentbiocompatibilityandstability.Biocompatibilityreferstotheabilityofamaterialtointeractwithbiologicalsystemswithoutcausingadverseeffects.InthecaseofQindaparticles,theyarewell-toleratedbycellsandhaveminimaltoxicity.Thisisacrucialfactorfortheirpotentialuseinmedicine.

Stabilityisanotheressentialcharacteristicofnanoparticles.Stabilityreferstotheabilityofamaterialtomaintainitsphysicalandchemicalpropertiesovertime.Nanoparticlescanbeunstableduetovariousfactors,suchastemperature,pH,orexposuretolight.Qindaparticleshavedemonstratedgoodstability,whichisaprerequisitefortheirpotentialuseinpharmaceuticalandbiomedicalapplications.

AnotherpotentialapplicationofQindaparticlesisinantibacterialtherapies.Inrecentyears,theemergenceofantibiotic-resistantbacteriahasbecomeasignificantchallengeforthetreatmentofinfectiousdiseases.Nanoparticles,includingQindaparticles,haveshownantibacterialpropertiesagainstvarioustypesofbacteria.However,furtherresearchisneededtofullyunderstandtheantibacterialmechanismsofQindaparticlesandtheirpotentialforuseinclinicalsettings.

In

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論